61 – 70 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
(
- Contribution to journal › Article
-
Mark
Metastatic spread in patients with gastric cancer
(
- Contribution to journal › Article
-
Mark
miR-204 suppresses the development and progression of human glioblastoma by targeting ATF2
(
- Contribution to journal › Article
-
Mark
Expression of the TPa and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer : Clinical significance and diagnostic potential
(
- Contribution to journal › Article
-
Mark
Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling
(
- Contribution to journal › Article
-
Mark
Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients
(
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
(
- Contribution to journal › Article
-
Mark
Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
(
- Contribution to journal › Article
-
Mark
STAT5 induces miR-21 expression in cutaneous T cell lymphoma
(
- Contribution to journal › Article